93 related articles for article (PubMed ID: 26738323)
21. Detection of NGF-receptors TrkA and p75NTR in human tumor cell lines and effect of NGF on the growth characteristic of the UT-7/EPO cell line.
Westphal G; van den Berg-Stein S; Braun K; Knoch TA; Dümmerling M; Langowski J; Debus J; Friedrich E
J Exp Clin Cancer Res; 2002 Jun; 21(2):255-67. PubMed ID: 12148587
[TBL] [Abstract][Full Text] [Related]
22. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma.
Sánchez C; Clementi M; Benitez D; Contreras H; Huidobro C; Castellón E
Prostate; 2005 Nov; 65(3):195-202. PubMed ID: 15948150
[TBL] [Abstract][Full Text] [Related]
23. SIGIRR/TIR8, an important regulator of TLR4 and IL-1R-mediated NF-κB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomas.
Bauman TM; Becka AJ; Sehgal PD; Huang W; Ricke WA
Hum Pathol; 2015 Nov; 46(11):1744-51. PubMed ID: 26344417
[TBL] [Abstract][Full Text] [Related]
24. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
[TBL] [Abstract][Full Text] [Related]
25. Dexamethasone induces TrkA and p75NTR immunoreactivity in the cerebral cortex and hippocampus.
Shi B; Mocchetti I
Exp Neurol; 2000 Apr; 162(2):257-67. PubMed ID: 10739632
[TBL] [Abstract][Full Text] [Related]
26. The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma.
Ødegaard E; Staff AC; Abeler VM; Kopolovic J; Onsrud M; Lazarovici P; Davidson B
Hum Pathol; 2007 Jan; 38(1):140-6. PubMed ID: 16996570
[TBL] [Abstract][Full Text] [Related]
27. Differences in the surface binding and endocytosis of neurotrophins by p75NTR.
Saxena S; Howe CL; Cosgaya JM; Hu M; Weis J; Krüttgen A
Mol Cell Neurosci; 2004 Jun; 26(2):292-307. PubMed ID: 15207854
[TBL] [Abstract][Full Text] [Related]
28. Differential up-regulation of erythropoietin and its receptor in benign and malignant prostatic tissue.
Xu C; Zhou T; He M; Sun Y
Urol Oncol; 2010; 28(3):314-9. PubMed ID: 19070519
[TBL] [Abstract][Full Text] [Related]
29. GDI2 is a target of paclitaxel that affects tumorigenesis of prostate cancer via the p75NTR signaling pathway.
Liu C; Wang W; Lin P; Xie H; Jiang S; Jia H; Li R; Wang N; Yu X
Biochem Biophys Res Commun; 2021 Jul; 562():119-126. PubMed ID: 34051575
[TBL] [Abstract][Full Text] [Related]
30. [Expressions of E-cadherin and alpha-catenin in benign, malignant and metastatic prostate tumors].
Jiang T; Jiang H; Su XM; Zheng L; Li QL; Zhang ZW; Li XC
Zhonghua Nan Ke Xue; 2012 Jun; 18(6):499-503. PubMed ID: 22774602
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma.
Festuccia C; Gravina GL; Muzi P; Pomante R; Ventura L; Ricevuto E; Vicentini C; Bologna M
Prostate; 2007 Sep; 67(12):1255-64. PubMed ID: 17596848
[TBL] [Abstract][Full Text] [Related]
32. [Correlation of the expressions of 4-HNE and GPC5 with the progression of prostate cancer].
Song Q; Yan HZ; Wang R; Zhang ZY; Zuo QJ; Song X
Zhonghua Nan Ke Xue; 2023 Jan; 29(1):19-24. PubMed ID: 37846827
[TBL] [Abstract][Full Text] [Related]
33. p75 Neurotrophin Receptor-Mediated Signaling Promotes Human Hair Follicle Regression (Catagen).
Peters EM; Stieglitz MG; Liezman C; Overall RW; Nakamura M; Hagen E; Klapp BF; Arck P; Paus R
Am J Pathol; 2006 Jan; 168(1):221-34. PubMed ID: 16400025
[TBL] [Abstract][Full Text] [Related]
34. LY294002 induces in vitro apoptosis and overexpression of p75NTR in human uterine leiomyosarcoma HTB 114 cells.
Pistilli A; Rende M; Crispoltoni L; Montagnoli C; Stabile AM
Growth Factors; 2015; 33(5-6):376-83. PubMed ID: 26653825
[TBL] [Abstract][Full Text] [Related]
35. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
36. TrkA and p75NTR in the ovary of adult cow and pig.
Levanti MB; Germanà A; Abbate F; Montalbano G; Vega JA; Germanà G
J Anat; 2005 Jul; 207(1):93-6. PubMed ID: 16011548
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
38. Necdin and TrkA contribute to modulation by p75NTR of resistance to oxidant stress.
Ingraham CA; Schor NF
Exp Cell Res; 2009 Dec; 315(20):3532-42. PubMed ID: 19818769
[TBL] [Abstract][Full Text] [Related]
39. [Expression of PIM-1 in prostate cancer tissue and its relationship with PSA recurrence].
Zhang CT; Xu Y; Luo F; Zhang ZH; Liu RL; Yang K; Ma BJ
Zhonghua Nan Ke Xue; 2012 Apr; 18(4):323-6. PubMed ID: 22574367
[TBL] [Abstract][Full Text] [Related]
40. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
Zhigang Z; Wenlv S
Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
